Machine learning enables cheaper and safer low-power MRI

FHS
May 10, 2024
4:25 pm

Machine learning enables cheaper and safer low-power magnetic resonance imaging (MRI) without sacrificing accuracy, according to a new study.

Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s

January 26, 2024

With subpar sales for Leqembi, Eisai delays Alzheimer’s patient goal deadline

Eisai said it could struggle to meet uptake targets for its Biogen-partnered Alzheimer’s drug Leqembi by the end of March as it detailed disappointing fiscal

February 7, 2024

iOnctura raises nearly $86m in Series B to fund Phase II cancer trials

Syncona was the major investor in iOnctura having invested €30m ($32.2m) for a 23% stake in the company. Image Credit: eamesBot / Shutterstock. Swiss biopharma

June 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.